This story has been updated from a previous version to clarify the timeline for growth of the Spotfire installed base. NEW YORK – Nearly three years since BioMérieux launched its smaller, faster take ...
CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...
NEW YORK – The European Commission on Tuesday proposed a new regulation that would amend the In Vitro Diagnostic Regulation (IVDR) with the goal of "simplifying and reducing the burden of the rules" ...
NEW YORK – An investor holding stake in OraSure Technologies, Altai Capital Management, announced Wednesday that it intends to nominate two candidates to OraSure's board of directors, hinting at a ...
Launched less than three years ago, the system may be changing how point-of-care tests are used in doctor's offices and emergency rooms.
Top Five Articles on 360Dx Last Week: Roche Vaginitis Test; FDA Reclassification of CDx Assays; More
Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.
Protavio is leading the development of the IVD-grade test kit, while Repado is developing the test's analysis software.
Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.
The man unlawfully billed Medicare for hundreds of millions of dollars as part of a cancer genetics and cardiovascular genetics testing scheme, according to the DOJ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results